1. Home
  2. TENX vs HUBC Comparison

TENX vs HUBC Comparison

Compare TENX & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • HUBC
  • Stock Information
  • Founded
  • TENX 1967
  • HUBC 2017
  • Country
  • TENX United States
  • HUBC Israel
  • Employees
  • TENX N/A
  • HUBC N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • TENX Health Care
  • HUBC
  • Exchange
  • TENX Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • TENX 19.5M
  • HUBC 15.2M
  • IPO Year
  • TENX N/A
  • HUBC N/A
  • Fundamental
  • Price
  • TENX $5.61
  • HUBC $0.43
  • Analyst Decision
  • TENX Strong Buy
  • HUBC
  • Analyst Count
  • TENX 4
  • HUBC 0
  • Target Price
  • TENX $20.67
  • HUBC N/A
  • AVG Volume (30 Days)
  • TENX 67.9K
  • HUBC 1.0M
  • Earning Date
  • TENX 11-13-2024
  • HUBC 12-13-2024
  • Dividend Yield
  • TENX N/A
  • HUBC N/A
  • EPS Growth
  • TENX N/A
  • HUBC N/A
  • EPS
  • TENX N/A
  • HUBC N/A
  • Revenue
  • TENX N/A
  • HUBC $33,357,000.00
  • Revenue This Year
  • TENX N/A
  • HUBC N/A
  • Revenue Next Year
  • TENX N/A
  • HUBC N/A
  • P/E Ratio
  • TENX N/A
  • HUBC N/A
  • Revenue Growth
  • TENX N/A
  • HUBC N/A
  • 52 Week Low
  • TENX $2.77
  • HUBC $0.37
  • 52 Week High
  • TENX $27.36
  • HUBC $2.48
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.30
  • HUBC 43.97
  • Support Level
  • TENX $5.70
  • HUBC $0.37
  • Resistance Level
  • TENX $6.01
  • HUBC $0.60
  • Average True Range (ATR)
  • TENX 0.47
  • HUBC 0.07
  • MACD
  • TENX -0.08
  • HUBC -0.01
  • Stochastic Oscillator
  • TENX 12.15
  • HUBC 26.11

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: